TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs62294780
log Bayes Factor = 11.4238
Chromosome 3   position 192,379,613  (GRCh37) Explore rs62294780 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Chapter II Neoplasms
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
C15-C26 Malignant neoplasms of digestive organs
1.000 0.000 0.000
Chapter X Diseases of the respiratory system
0.998 0.002 0.000
Chapter I Certain infectious and parasitic diseases
0.998 0.002 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.996 0.004 0.000
Chapter XX External causes of morbidity and mortality
0.996 0.004 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.995 0.005 0.000
K70-K77 Diseases of liver
0.995 0.005 0.000
Chapter XI Diseases of the digestive system
0.994 0.006 0.000
K70 Alcoholic liver disease
0.993 0.007 0.000
J95-J99 Other diseases of the respiratory system
0.992 0.008 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.987 0.013 0.000
J98 Other respiratory disorders
0.986 0.014 0.000
A30-A49 Other bacterial diseases
0.985 0.015 0.000
J98.1 Pulmonary collapse
0.983 0.017 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.980 0.020 0.000
C64-C68 Malignant neoplasms of urinary tract
0.979 0.021 0.000
C18 Malignant neoplasm of colon
0.977 0.023 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.972 0.028 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.970 0.030 0.000
D69 Purpura and other haemorrhagic conditions
0.968 0.032 0.000
A41 Other septicaemia
0.963 0.037 0.000
J90-J94 Other diseases of pleura
0.963 0.037 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.962 0.038 0.000
C18.0 Caecum
0.959 0.041 0.000
Y43 Primarily systemic agents
0.957 0.043 0.000
C51-C58 Malignant neoplasms of female genital organs
0.956 0.044 0.000
K70.9 Alcoholic liver disease, unspecified
0.955 0.045 0.000
S50-S59 Injuries to the elbow and forearm
0.953 0.047 0.000
K90-K93 Other diseases of the digestive system
0.949 0.051 0.000
D69.6 Thrombocytopenia, unspecified
0.939 0.061 0.000
C25 Malignant neoplasm of pancreas
0.935 0.065 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.927 0.073 0.000
Y43.3 Other antineoplastic drugs
0.926 0.074 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.920 0.080 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.913 0.087 0.000
C64 Malignant neoplasm of kidney, except renal pelvis
0.913 0.087 0.000
S52 Fracture of forearm
0.911 0.089 0.000
Y42.7 Androgens and anabolic congeners
0.908 0.092 0.000
K70.3 Alcoholic cirrhosis of liver
0.908 0.092 0.000
J91 Pleural effusion in conditions classified elsewhere
0.903 0.097 0.000
C67 Malignant neoplasm of bladder
0.902 0.098 0.000
J30-J39 Other diseases of upper respiratory tract
0.902 0.098 0.000
A41.9 Septicaemia, unspecified
0.902 0.098 0.000
K74 Fibrosis and cirrhosis of liver
0.897 0.103 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.896 0.104 0.000
K70.4 Alcoholic hepatic failure
0.894 0.106 0.000
J33 Nasal polyp
0.889 0.111 0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified
0.885 0.115 0.000
K90 Intestinal malabsorption
0.883 0.117 0.000
A00-A09 Intestinal infectious diseases
0.875 0.125 0.000
C79 Secondary malignant neoplasm of other sites
0.875 0.125 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.867 0.133 0.000
C25.0 Head of pancreas
0.864 0.136 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.863 0.137 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.862 0.138 0.000
C16 Malignant neoplasm of stomach
0.862 0.138 0.000
T79-T79 Certain early complications of trauma
0.862 0.138 0.000
C83.3 Large cell (diffuse)
0.860 0.140 0.000
K80-K87 Disorders of gallbladder, biliary tract and pancreas
0.858 0.142 0.000
A41.0 Septicaemia due to Staphylococcus aureus
0.857 0.143 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.857 0.143 0.000
Chapter XXII Codes for special purposes
0.853 0.147 0.000
J33.0 Polyp of nasal cavity
0.853 0.147 0.000
C20 Malignant neoplasm of rectum
0.852 0.148 0.000
K70.1 Alcoholic hepatitis
0.852 0.148 0.000
B15-B19 Viral hepatitis
0.851 0.149 0.000
S52.6 Fracture of lower end of both ulna and radius
0.849 0.151 0.000
J90 Pleural effusion, not elsewhere classified
0.848 0.152 0.000
K65-K67 Diseases of peritoneum
0.847 0.153 0.000
S52.0 Fracture of upper end of ulna
0.847 0.153 0.000
Y52 Agents primarily affecting the cardiovascular system
0.846 0.154 0.000
C54 Malignant neoplasm of corpus uteri
0.845 0.155 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.843 0.157 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.843 0.157 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.839 0.161 0.000
A04 Other bacterial intestinal infections
0.838 0.162 0.000
S50 Superficial injury of forearm
0.837 0.163 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.834 0.166 0.000
K70.0 Alcoholic fatty liver
0.833 0.167 0.000
A46 Erysipelas
0.832 0.168 0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified
0.824 0.176 0.000
C53 Malignant neoplasm of cervix uteri
0.824 0.176 0.000
X60-X84 Intentional self-harm
0.824 0.176 0.000
C22.1 Intrahepatic bile duct carcinoma
0.822 0.178 0.000
Chapter XXI Factors influencing health status and contact with health services
0.822 0.178 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.818 0.182 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.816 0.184 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.816 0.184 0.000
S40-S49 Injuries to the shoulder and upper arm
0.815 0.185 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.814 0.186 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.813 0.187 0.000
C17 Malignant neoplasm of small intestine
0.807 0.193 0.000
K74.6 Other and unspecified cirrhosis of liver
0.806 0.194 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.806 0.194 0.000
K81 Cholecystitis
0.805 0.195 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.804 0.196 0.000
S52.60 Fracture of lower end of both ulna and radius (closed)
0.804 0.196 0.000
J60-J70 Lung diseases due to external agents
0.804 0.196 0.000
K72 Hepatic failure, not elsewhere classified
0.802 0.198 0.000
V10-V19 Pedal cyclist injured in transport accident
0.802 0.198 0.000
C80 Malignant neoplasm without specification of site
0.802 0.198 0.000
S52.00 Fracture of upper end of ulna (closed)
0.801 0.199 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.801 0.199 0.000
Y42.5 Other oestrogens and progestogens
0.801 0.199 0.000
C18.2 Ascending colon
0.800 0.200 0.000
C18.1 Appendix
0.800 0.200 0.000
Z00-Z13 Persons encountering health services for examination and investigation
0.799 0.201 0.000
K76 Other diseases of liver
0.798 0.201 0.000
A04.5 Campylobacter enteritis
0.795 0.205 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.795 0.205 0.000
J33.9 Nasal polyp, unspecified
0.793 0.207 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.793 0.207 0.000
K90.0 Coeliac disease
0.792 0.208 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.791 0.209 0.000
D80-D89 Certain disorders involving the immune mechanism
0.789 0.211 0.000
A04.7 Enterocolitis due to Clostridium difficile
0.789 0.211 0.000
Y40 Systemic antibiotics
0.788 0.212 0.000
Z08 Follow-up examination after treatment for malignant neoplasm
0.787 0.213 0.000
Z04 Examination and observation for other reasons
0.785 0.215 0.000
D69.0 Allergic purpura
0.785 0.215 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.784 0.216 0.000
C18.7 Sigmoid colon
0.780 0.220 0.000
Chapter VI Diseases of the nervous system
0.779 0.221 0.000
K75 Other inflammatory liver diseases
0.778 0.222 0.000
C15 Malignant neoplasm of oesophagus
0.777 0.223 0.000
T79 Certain early complications of trauma, not elsewhere classified
0.777 0.223 0.000
Z04.8 Examination and observation for other specified reasons
0.777 0.223 0.000
C16.0 Cardia
0.777 0.223 0.000
C90.0 Multiple myeloma
0.774 0.226 0.000
J99 Respiratory disorders in diseases classified elsewhere
0.774 0.226 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.772 0.228 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.772 0.228 0.000
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source
0.772 0.228 0.000
W50-W64 Exposure to animate mechanical forces
0.771 0.229 0.000
D70 Agranulocytosis
0.771 0.229 0.000
C67.1 Dome of bladder
0.771 0.229 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.769 0.231 0.000
S70-S79 Injuries to the hip and thigh
0.768 0.232 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.768 0.232 0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm
0.765 0.235 0.000
C54.1 Endometrium
0.765 0.235 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.763 0.237 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.763 0.237 0.000
A41.1 Septicaemia due to other specified staphylococcus
0.762 0.238 0.000
C25.9 Pancreas, unspecified
0.762 0.238 0.000
C21 Malignant neoplasm of anus and anal canal
0.759 0.241 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.759 0.241 0.000
C88 Malignant immunoproliferative diseases
0.756 0.244 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.756 0.244 0.000
K81.9 Cholecystitis, unspecified
0.756 0.244 0.000
B95-B98 Bacterial, viral and other infectious agents
0.755 0.245 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.753 0.247 0.000
C67.2 Lateral wall of bladder
0.753 0.247 0.000
A41.2 Septicaemia due to unspecified staphylococcus
0.752 0.248 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.751 0.249 0.000
J94 Other pleural conditions
0.751 0.249 0.000
A48 Other bacterial diseases, not elsewhere classified
0.750 0.250 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.749 0.251 0.000
J98.4 Other disorders of lung
0.749 0.251 0.000
C67.4 Posterior wall of bladder
0.748 0.252 0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified
0.748 0.252 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.746 0.254 0.000
C77.2 Intra-abdominal lymph nodes
0.746 0.254 0.000
J98.8 Other specified respiratory disorders
0.746 0.254 0.000
C66 Malignant neoplasm of ureter
0.745 0.255 0.000
J20-J22 Other acute lower respiratory infections
0.745 0.255 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.743 0.257 0.000
S10-S19 Injuries to the neck
0.743 0.257 0.000
K83 Other diseases of biliary tract
0.742 0.258 0.000
X10-X19 Contact with heat and hot substances
0.742 0.258 0.000
C84.4 Peripheral T-cell lymphoma
0.741 0.259 0.000
K65 Peritonitis
0.739 0.261 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.739 0.261 0.000
S80-S89 Injuries to the knee and lower leg
0.738 0.262 0.000
K74.3 Primary biliary cirrhosis
0.737 0.262 0.000
B25-B34 Other viral diseases
0.735 0.265 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.734 0.266 0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
0.734 0.266 0.000
C79.6 Secondary malignant neoplasm of ovary
0.734 0.266 0.000
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis
0.733 0.267 0.000
C83.1 Small cleaved cell (diffuse)
0.733 0.267 0.000
C91 Lymphoid leukaemia
0.733 0.267 0.000
A40 Streptococcal septicaemia
0.732 0.268 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.731 0.269 0.000
V40-V49 Car occupant injured in transport accident
0.731 0.269 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.731 0.269 0.000
D55-D59 Haemolytic anaemias
0.730 0.270 0.000
C18.6 Descending colon
0.728 0.272 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.727 0.273 0.000
C51 Malignant neoplasm of vulva
0.722 0.278 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.721 0.279 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.721 0.279 0.000
J85-J86 Suppurative and necrotic conditions of lower respiratory tract
0.720 0.280 0.000
C67.0 Trigone of bladder
0.719 0.281 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.718 0.282 0.000
J33.8 Other polyp of sinus
0.718 0.282 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.718 0.282 0.000
S50.9 Superficial injury of forearm, unspecified
0.718 0.282 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
C23 Malignant neoplasm of gallbladder
0.717 0.283 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.716 0.284 0.000
B50-B64 Protozoal diseases
0.716 0.284 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.716 0.284 0.000
A75-A79 Rickettsioses
0.716 0.284 0.000
A70-A74 Other diseases caused by chlamydiae
0.716 0.284 0.000
A65-A69 Other spirochaetal diseases
0.716 0.284 0.000
A20-A28 Certain zoonotic bacterial diseases
0.716 0.284 0.000
A15-A19 Tuberculosis
0.716 0.284 0.000
Y43.0 Antiallergic and antiemetic drugs
0.716 0.284 0.000
B07 Viral warts
0.715 0.284 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.714 0.286 0.000
C95 Leukaemia of unspecified cell type
0.714 0.286 0.000
C94 Other leukaemias of specified cell type
0.714 0.286 0.000
C93 Monocytic leukaemia
0.714 0.286 0.000
C86 Other specified types of T/NK-cell lymphoma
0.714 0.286 0.000
Y35-Y36 Legal intervention and operations of war
0.714 0.286 0.000
Y10-Y34 Event of undetermined intent
0.714 0.286 0.000
Y00-Y09 Assault
0.714 0.286 0.000
X85-X99 Assault
0.714 0.286 0.000
X30-X39 Exposure to forces of nature
0.714 0.286 0.000
X00-X09 Exposure to smoke, fire and flames
0.714 0.286 0.000
W75-W84 Other accidental threats to breathing
0.714 0.286 0.000
W65-W74 Accidental drowning and submersion
0.714 0.286 0.000
V98-V99 Other and unspecified transport accidents
0.714 0.286 0.000
V95-V97 Air and space transport accidents
0.714 0.286 0.000
V90-V94 Water transport accidents
0.714 0.286 0.000
V70-V79 Bus occupant injured in transport accident
0.714 0.286 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.714 0.286 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.714 0.286 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.714 0.286 0.000
V01-V09 Pedestrian injured in transport accident
0.714 0.286 0.000
J39 Other diseases of upper respiratory tract
0.714 0.286 0.000
X50-X57 Overexertion, travel and privation
0.714 0.286 0.000
X20-X29 Contact with venomous animals and plants
0.714 0.286 0.000
C81 Hodgkin's disease
0.714 0.286 0.000
Y59 Other and unspecified vaccines and biological substances
0.713 0.287 0.000
Y58 Bacterial vaccines
0.713 0.287 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.713 0.287 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.713 0.287 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.713 0.287 0.000
Y48 Anaesthetics and therapeutic gases
0.713 0.287 0.000
K77 Liver disorders in diseases classified elsewhere
0.713 0.287 0.000
K71 Toxic liver disease
0.713 0.287 0.000
K70.2 Alcoholic fibrosis and sclerosis of liver
0.712 0.288 0.000
K81.1 Chronic cholecystitis
0.712 0.288 0.000
S56 Injury of muscle and tendon at forearm level
0.711 0.289 0.000
D66 Hereditary factor VIII deficiency
0.711 0.289 0.000
J96 Respiratory failure, not elsewhere classified
0.711 0.289 0.000
J95 Postprocedural respiratory disorders, not elsewhere classified
0.711 0.289 0.000
K91.1 Postgastric surgery syndromes
0.710 0.289 0.000
A02 Other Salmonella infections
0.710 0.290 0.000
A80-A89 Viral infections of the central nervous system
0.709 0.291 0.000
K73 Chronic hepatitis, not elsewhere classified
0.709 0.291 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.708 0.292 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.708 0.292 0.000
J98.6 Disorders of diaphragm
0.707 0.293 0.000
J98.5 Diseases of mediastinum, not elsewhere classified
0.707 0.293 0.000
J98.3 Compensatory emphysema
0.707 0.293 0.000
J98.2 Interstitial emphysema
0.707 0.293 0.000
A44 Bartonellosis
0.706 0.294 0.000
A43 Nocardiosis
0.706 0.294 0.000
A42 Actinomycosis
0.706 0.294 0.000
A39 Meningococcal infection
0.706 0.294 0.000
A37 Whooping cough
0.706 0.294 0.000
A36 Diphtheria
0.706 0.294 0.000
A32 Listeriosis
0.706 0.294 0.000
A31 Infection due to other mycobacteria
0.706 0.294 0.000
A30 Leprosy [Hansen's disease]
0.706 0.294 0.000
A38 Scarlet fever
0.706 0.294 0.000
A35 Other tetanus
0.706 0.294 0.000
A34 Obstetrical tetanus
0.706 0.294 0.000
A33 Tetanus neonatorum
0.706 0.294 0.000
K90.9 Intestinal malabsorption, unspecified
0.706 0.294 0.000
B99-B99 Other infectious diseases
0.706 0.294 0.000
G62 Other polyneuropathies
0.704 0.296 0.000
T79.7 Traumatic subcutaneous emphysema
0.703 0.297 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.703 0.297 0.000
T33-T35 Frostbite
0.703 0.297 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.703 0.297 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.703 0.297 0.000
T00-T07 Injuries involving multiple body regions
0.703 0.297 0.000
L80-L99 Other disorders of the skin and subcutaneous tissue
0.703 0.297 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.702 0.298 0.000
C65 Malignant neoplasm of renal pelvis
0.702 0.298 0.000
B91 Sequelae of poliomyelitis
0.702 0.298 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.701 0.299 0.000
C18.8 Overlapping lesion of colon
0.701 0.299 0.000
C80.9 Malignant neoplasm, unspecified
0.700 0.300 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.699 0.301 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.698 0.302 0.000
K65.0 Acute peritonitis
0.697 0.302 0.000
D67 Hereditary factor IX deficiency
0.697 0.303 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.697 0.303 0.000
S52.4 Fracture of shafts of both ulna and radius
0.697 0.303 0.000
A41.8 Other specified septicaemia
0.696 0.304 0.000
Y42.9 Other and unspecified hormone antagonists
0.695 0.304 0.000
Y42.4 Oral contraceptives
0.695 0.304 0.000
Y42.2 Antithyroid drugs
0.695 0.304 0.000
Y42.1 Thyroid hormones and substitutes
0.695 0.304 0.000
C18.3 Hepatic flexure
0.695 0.304 0.000
C18.4 Transverse colon
0.694 0.306 0.000
D69.9 Haemorrhagic condition, unspecified
0.694 0.306 0.000
D69.8 Other specified haemorrhagic conditions
0.694 0.306 0.000
D69.5 Secondary thrombocytopenia
0.694 0.306 0.000
D69.4 Other primary thrombocytopenia
0.694 0.306 0.000
D69.2 Other nonthrombocytopenic purpura
0.694 0.306 0.000
D69.1 Qualitative platelet defects
0.694 0.306 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.693 0.307 0.000
C53.9 Cervix uteri, unspecified
0.693 0.307 0.000
A41.4 Septicaemia due to anaerobes
0.690 0.309 0.000
A41.3 Septicaemia due to Haemophilus influenzae
0.690 0.309 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.690 0.310 0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.689 0.311 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.687 0.313 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.687 0.313 0.000
Y43.9 Primarily systemic agent, unspecified
0.686 0.314 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.686 0.314 0.000
Y43.6 Enzymes, not elsewhere classified
0.686 0.314 0.000
Y43.5 Acidifying and alkalising agents
0.686 0.314 0.000
Y43.4 Immunosuppressive agents
0.686 0.314 0.000
Y43.2 Antineoplastic natural products
0.686 0.314 0.000
Y43.1 Antineoplastic antimetabolites
0.686 0.314 0.000
C58 Malignant neoplasm of placenta
0.686 0.314 0.000
C52 Malignant neoplasm of vagina
0.686 0.314 0.000
A49 Bacterial infection of unspecified site
0.685 0.315 0.000
V20-V29 Motorcycle rider injured in transport accident
0.684 0.316 0.000
B18 Chronic viral hepatitis
0.684 0.316 0.000
S59 Other and unspecified injuries of forearm
0.684 0.316 0.000
S58 Traumatic amputation of forearm
0.684 0.316 0.000
S57 Crushing injury of forearm
0.684 0.316 0.000
S55 Injury of blood vessels at forearm level
0.684 0.316 0.000
S54 Injury of nerves at forearm level
0.684 0.316 0.000
S53 Dislocation, sprain and strain of joints and ligaments of elbow
0.684 0.316 0.000
B65-B83 Helminthiases
0.682 0.317 0.000
S46 Injury of muscle and tendon at shoulder and upper arm level
0.682 0.318 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.682 0.318 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.680 0.319 0.000
C79.2 Secondary malignant neoplasm of skin
0.680 0.320 0.000
K93 Disorders of other digestive organs in diseases classified elsewhere
0.680 0.320 0.000
C56 Malignant neoplasm of ovary
0.677 0.323 0.000
B17 Other acute viral hepatitis
0.676 0.324 0.000
T43.6 Psychostimulants with abuse potential
0.676 0.324 0.000
K35-K38 Diseases of appendix
0.674 0.326 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.672 0.327 0.000
K76.9 Liver disease, unspecified
0.671 0.329 0.000
S50.0 Contusion of elbow
0.670 0.330 0.000
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified
0.670 0.330 0.000
C25.8 Overlapping lesion of pancreas
0.670 0.330 0.000
C25.7 Other parts of pancreas
0.670 0.330 0.000
C25.4 Endocrine pancreas
0.670 0.330 0.000
C25.3 Pancreatic duct
0.670 0.330 0.000
C25.2 Tail of pancreas
0.670 0.330 0.000
C25.1 Body of pancreas
0.670 0.330 0.000
V80-V89 Other land transport accidents
0.669 0.330 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.669 0.331 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.669 0.331 0.000
C84.5 Other and unspecified T-cell lymphomas
0.669 0.331 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.669 0.331 0.000
J09-J18 Influenza and pneumonia
0.668 0.332 0.000
J98.9 Respiratory disorder, unspecified
0.668 0.332 0.000
W20-W49 Exposure to inanimate mechanical forces
0.667 0.333 0.000
J37 Chronic laryngitis and laryngotracheitis
0.667 0.333 0.000
C24.0 Extrahepatic bile duct
0.667 0.333 0.000
J38.1 Polyp of vocal cord and larynx
0.667 0.333 0.000
Y52.1 Calcium-channel blockers
0.665 0.335 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.665 0.335 0.000
C83.7 Burkitt's tumour
0.665 0.335 0.000
C83.6 Undifferentiated (diffuse)
0.665 0.335 0.000
C83.5 Lymphoblastic (diffuse)
0.665 0.335 0.000
C83.4 Immunoblastic (diffuse)
0.665 0.335 0.000
C83.2 Mixed small and large cell (diffuse)
0.665 0.335 0.000
C22.9 Liver, unspecified
0.664 0.336 0.000
K91.4 Colostomy and enterostomy malfunction
0.663 0.336 0.000
Y57 Other and unspecified drugs and medicaments
0.663 0.337 0.000
J92 Pleural plaque
0.663 0.337 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.663 0.337 0.000
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
0.663 0.337 0.000
Y47.1 Benzodiazepines
0.662 0.338 0.000
K76.6 Portal hypertension
0.661 0.339 0.000
D50-D53 Nutritional anaemias
0.660 0.340 0.000
Z04.3 Examination and observation following other accident
0.660 0.340 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.659 0.340 0.000
C85.0 Lymphosarcoma
0.659 0.340 0.000
K74.5 Biliary cirrhosis, unspecified
0.659 0.341 0.000
S70 Superficial injury of hip and thigh
0.659 0.341 0.000
J69 Pneumonitis due to solids and liquids
0.657 0.343 0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm
0.657 0.343 0.000
J80-J84 Other respiratory diseases principally affecting the interstitium
0.656 0.344 0.000
B94 Sequelae of other and unspecified infectious and parasitic diseases
0.655 0.344 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.656 0.344 0.000
C53.0 Endocervix
0.655 0.345 0.000
G61 Inflammatory polyneuropathy
0.655 0.345 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.654 0.346 0.000
Z02 Examination and encounter for administrative purposes
0.654 0.346 0.000
S52.2 Fracture of shaft of ulna
0.653 0.346 0.000
S52.9 Fracture of forearm, part unspecified
0.653 0.347 0.000
S52.7 Multiple fractures of forearm
0.653 0.347 0.000
S52.3 Fracture of shaft of radius
0.653 0.347 0.000
Chapter V Mental and behavioural disorders
0.653 0.347 0.000
Y40.3 Macrolides
0.653 0.347 0.000
G62.9 Polyneuropathy, unspecified
0.651 0.349 0.000
G80-G83 Cerebral palsy and other paralytic syndromes
0.650 0.350 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.650 0.350 0.000
L98.8 Other specified disorders of skin and subcutaneous tissue
0.650 0.350 0.000
C85.1 B-cell lymphoma, unspecified
0.649 0.351 0.000
B00 Herpesviral [herpes simplex] infections
0.649 0.351 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.648 0.352 0.000
J35 Chronic diseases of tonsils and adenoids
0.648 0.352 0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.648 0.352 0.000
A41.5 Septicaemia due to other Gram-negative organisms
0.647 0.353 0.000
C67.8 Overlapping lesion of bladder
0.647 0.353 0.000
C67.7 Urachus
0.647 0.353 0.000
C67.5 Bladder neck
0.647 0.353 0.000
C67.3 Anterior wall of bladder
0.647 0.353 0.000
Chapter IX Diseases of the circulatory system
0.647 0.353 0.000
C17.0 Duodenum
0.645 0.355 0.000
K83.0 Cholangitis
0.645 0.355 0.000
Y40.8 Other systemic antibiotics
0.645 0.355 0.000
K76.8 Other specified diseases of liver
0.644 0.356 0.000
K74.4 Secondary biliary cirrhosis
0.643 0.357 0.000
K74.2 Hepatic fibrosis with hepatic sclerosis
0.643 0.357 0.000
K74.1 Hepatic sclerosis
0.643 0.357 0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
0.643 0.357 0.000
C22.7 Other specified carcinomas of liver
0.642 0.358 0.000
C22.4 Other sarcomas of liver
0.642 0.358 0.000
C22.3 Angiosarcoma of liver
0.642 0.358 0.000
C22.2 Hepatoblastoma
0.642 0.358 0.000
S51 Open wound of forearm
0.641 0.359 0.000
U82-U85 Resistance to antimicrobial and antineoplastic drugs
0.640 0.360 0.000
S20-S29 Injuries to the thorax
0.640 0.360 0.000
T29-T32 Burns and corrosions of multiple and unspecified body regions
0.639 0.361 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.638 0.362 0.000
C45 Mesothelioma
0.638 0.362 0.000
J33.1 Polypoid sinus degeneration
0.637 0.362 0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm
0.638 0.362 0.000
J93 Pneumothorax
0.636 0.364 0.000
L92 Granulomatous disorders of skin and subcutaneous tissue
0.636 0.364 0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm
0.635 0.365 0.000
S43 Dislocation, sprain and strain of joints and ligaments of shoulder girdle
0.635 0.365 0.000
K91.9 Postprocedural disorder of digestive system, unspecified
0.634 0.366 0.000
K91.5 Postcholecystectomy syndrome
0.634 0.366 0.000
K91.2 Postsurgical malabsorption, not elsewhere classified
0.634 0.366 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.634 0.366 0.000
B16 Acute hepatitis B
0.633 0.366 0.000
K90.8 Other intestinal malabsorption
0.633 0.367 0.000
K90.3 Pancreatic steatorrhoea
0.633 0.367 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.633 0.367 0.000
K90.1 Tropical sprue
0.633 0.367 0.000
S80 Superficial injury of lower leg
0.633 0.367 0.000
K75.0 Abscess of liver
0.633 0.367 0.000
T20 Burn and corrosion of head and neck
0.631 0.369 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.631 0.369 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.631 0.369 0.000
K72.0 Acute and subacute hepatic failure
0.630 0.370 0.000
K75.8 Other specified inflammatory liver diseases
0.629 0.371 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.629 0.371 0.000
A07 Other protozoal intestinal diseases
0.628 0.372 0.000
A06 Amoebiasis
0.628 0.372 0.000
A05 Other bacterial foodborne intoxications
0.628 0.372 0.000
A03 Shigellosis
0.628 0.372 0.000
A01 Typhoid and paratyphoid fevers
0.628 0.372 0.000
A00 Cholera
0.628 0.372 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.627 0.372 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.627 0.372 0.000
S52.8 Fracture of other parts of forearm
0.626 0.374 0.000
L20-L30 Dermatitis and eczema
0.626 0.374 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.626 0.374 0.000
I26 Pulmonary embolism
0.626 0.374 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.625 0.375 0.000
T91 Sequelae of injuries of neck and trunk
0.624 0.376 0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances
0.623 0.377 0.000
K91.3 Postoperative intestinal obstruction
0.623 0.377 0.000
C90.3 Solitary plasmacytoma
0.621 0.379 0.000
C90.2 Plasmacytoma, extramedullary
0.621 0.379 0.000
C90.1 Plasma cell leukaemia
0.621 0.379 0.000
B98 Other specified infectious agents as the cause of diseases classified to other chapters
0.621 0.379 0.000
S49 Other and unspecified injuries of shoulder and upper arm
0.621 0.379 0.000
D86 Sarcoidosis
0.621 0.379 0.000
B15 Acute hepatitis A
0.620 0.380 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.620 0.380 0.000
K72.9 Hepatic failure, unspecified
0.620 0.380 0.000
V18 Pedal cyclist injured in noncollision transport accident
0.619 0.381 0.000
K83.1 Obstruction of bile duct
0.619 0.381 0.000
Y56.9 Topical agent, unspecified
0.619 0.381 0.000
Y56.8 Other topical agents
0.619 0.381 0.000
Y56.7 Dental drugs, topically applied
0.619 0.381 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.619 0.381 0.000
Y56.5 Ophthalmological drugs and preparations
0.619 0.381 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.619 0.381 0.000
Y56.3 Emollients, demulcents and protectants
0.619 0.381 0.000
Y56.2 Local astringents and local detergents
0.619 0.381 0.000
Y56.1 Antipruritics
0.619 0.381 0.000
E20-E35 Disorders of other endocrine glands
0.618 0.382 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.618 0.382 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.618 0.382 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.618 0.382 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.618 0.382 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.